Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.11

-2.6%

Nov 7 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (372)	9/7/1999 4:47:00 PM
From: Biomaven	Read Replies (2) of 52153

Well some of the genomics companies certainly have been performing recently. MLNM, HGSI and AFFX have been rockets. Fortunately I succumbed to the hype a few weeks back and bought a little HGSI to go with my bigger MLNM stake, but alas I've been eyeing AFFX for ever so long without ever taking the plunge. At the end of the day some of the lower tier stuff started to move too, like GLGC and CRGN. I sold the latter when it popped recently - looks like that that was a mistake. In general the old "sell on the pop" strategy seems not to be right currently - I'm still regretting the VPHM I sold when it popped recently. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next